Harrisson S et al. Six month interim results of MSDC-0602K in a large phase 2b NASH study demonstrate significant improvement in liver enzymes and glycemic control (NCT02784444). (Abstract PS-111)
Silencing van het hepatitis B-virus S-gen door CRISPR‐gemedieerde base editing
feb 2020 | Hepatitis, Hepatologie, Virale infecties